Study to Evaluate Injection Pain and Local Tolerability Following Administration of TV-46046

Study Title

A Study to Evaluate Injection Pain and Local Tolerability Following Subcutaneous Administration of TV-46046

Teva Identifier

TV46046-WH-10147

ClinicalTrials.gov Identifier

NCT03700658

Study Status

Completed

Trial Condition(s)

Contraception

Interventions

Drug: TV-46046 - 1 | Drug: TV-46046 - 2 | Drug: medroxyprogesterone acetate injectable suspension | Drug: TV-46046 Placebo

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
ClinicalTrials.gov study records with inclusion and exclusion criteria
female icon for clinical trials

Key Participation Requirements

Gender

Female

Age Range

18 Years to 50 Years

Trial Duration

December 14, 2018 - October 2, 2020

Phase

Phase 1

Study Type

Interventional